TEMSIROLIMUS (has an active metabolite) | TEMSIROLIMUS | ATC L01XE09
ANTINEOPLASTIC AGENTS TREATMENT OF ADVANCED RENAL CELL CARCINOMA PROTEIN-PROTEIN INTERACTION INHIBITOR FKBP12 / MTOR (MAMMALIAN TARGET OF RAPAMYCIN) TREATMENT OF MANTLE CELL LYMPHOMA (MCL) (DRUG FOR RARE DISEASE IN EUROPE) | INTRAVENOUS | Cmax 056 MICROMOLAR (25 MILLIGRAM) VD 172 LITER Cl 16.2 LITER / HOUR HT 17.3 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | FK506 BINDING PROTEIN-12 (FKBP-12)/MTOR COMPLEX | FK506-BINDING PROTEIN 1A INHIBITOR CHEMBL1902 FK506-BINDING PROTEIN 1A P62942 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A HOMO SAPIENS ENZYME ISOMERASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |